The vast majority of drugs entering Chicago and the surrounding area, including fentanyl and fentanyl-related substances (FRS), heroin, cocaine, and methamphetamine, continue to be smuggled across the United States–Mexico border. Availability and abuse of these drugs is high, with opioids being the most prevalent in major cities and methamphetamine in...

The Fentanyl Signature Profiling Program (FSPP) performs in-depth chemical analyses on fentanyl and fentanyl-related exhibits obtained from seizures made throughout the United States. This report details the results and conclusions derived from these analyses that are reported on a quarterly basis. FSPP data is not intended to reflect U.S. market...

Prevenir El Uso De Marihuana Entre Adolescentes Y Adultos Jóvenes (Preventing Marijuana use in Youth and Young Adults)

This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is October 23, 2019 to March 28, 2021 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document...

The Drug Enforcement Administration (DEA) Chicago Field Division (CFD) conducted a study of all exhibits containing fentanyl and/or fentanyl-related substances (FRS) acquired within the CFD’s area of responsibility (AOR) between fiscal year (FY) 2015 and FY 2019 up to May 30, 2019. The CFD AOR includes the States of Illinois...

Vaping is the act of inhaling and exhaling an aerosol or vapor made from a liquid or dry material that is heated in an electronic powered device, called an electronic cigarette, or e-cigarette. In addition to nicotine and flavored liquids, marijuana concentrates can also be vaped. This 6-panel, double-sided trifold...

Spanish version of publication, Vaping and Marijuana Concentrates: What is Vaping? (October 2019).

The phenomenon of drug overdose death has grown steadily worse in the United States during most of the 21st century and has been skyrocketing since 2013 and the introduction of illicitly manufactured fentanyl-related substances into the domestic drug market...

Since 2014, the Drug Enforcement Administration (DEA) Philadelphia Division Intelligence Program (PDIP) has annually collected and analyzed data and disseminated perceived trends and key findings that concern drug-related overdose deaths in Pennsylvania. This analysis has informed a multi-disciplinary audience relating to the drugs, populations, and geographic areas of greatest concern...

The Drug Enforcement Administration (DEA) Philadelphia Division’s Intelligence Program (PDIP) reviewed a set of data indicators for the years 2015-2018 to assess the current prescription opioid threat in Pennsylvania. Analysis revealed that a positive change in the prescription opioid threat may be underway...